Aller au contenu principal
Laboratory experience reporting trisomy 16 and 22 from cell-free DNA screening: Diagnostic and clinical outcome data over a four-year period
Genome-wide cfDNA testing: Clinical laboratory experience screening for select microdeletions
Cell free DNA testing at 9 weeks: A clinical laboratory experience
Maternal fragile sites resulting in maternal mosaic deletions: an additional explanation for false positive cell-free DNA
Updated clinical experience with esoteric aneuploidies on a genome-wide cell-free DNA test
